FDA Approves First Treatment For Pompe Disease
Published by MSN Search News: "Food and Drug Administration" May 1st, 2006 in Regulatory Affairs
Medical News Today - The Food and Drug Administration today approved a biologics license application (BLA) for Myozyme (alglucosidase alfa, rhGAA), the first treatment for patients with Pompe disease, a rare but severely debilitating disease. Pompe disease, which affects ...